ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,652Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 789

$1.2M Total Retail Price of All Prescriptions

Rank: 66 out of 789

618 Patients Receiving at Least One Drug in Part D
78% Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Alabama
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 618 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

37% of this provider’s 618 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,842 1,074 219 S3 1 1
POTASSIUM CHLORIDE 1,114 936 173 2 14
OMEPRAZOLE 1,070 826 182 3 2
AMLODIPINE BESYLATE 880 714 125 4 4
PRAVASTATIN SODIUM 748 575 131 5 10
LEVOTHYROXINE SODIUM 710 566 105 6 3
ATORVASTATIN CALCIUM 600 463 107 7 8
BUMETANIDE 550 462 109 8 102
FUROSEMIDE 539 477 87 9 7
SIMVASTATIN 527 464 86 10 5
METOPROLOL SUCCINATE 513 449 68 11 20
PREDNISONE 472 381 190 12 46
LORAZEPAM 415 296 69 B 13 37
GABAPENTIN 415 320 78 13 11
LEVOCETIRIZINE DIHYDROCHLORIDE 398 262 149 15 157
METFORMIN HCL 367 249 52 16 9
TRAMADOL HCL 364 297 74 17 17
CARVEDILOL 351 299 67 18 16
CITALOPRAM HBR 341 286 49 19 25
CLOPIDOGREL 341 256 53 19 23
METOPROLOL TARTRATE 339 298 57 21 22
DONEPEZIL HCL 325 325 41 22 39
SERTRALINE HCL 323 249 39 23 28
NEXIUM 308 229 42 24 24
WARFARIN SODIUM 305 256 35 25 27
ATENOLOL 288 216 41 26 26
MONTELUKAST SODIUM 284 184 47 27 40
CEFDINIR 278 212 174 28 173
PANTOPRAZOLE SODIUM 278 215 41 28 19
ALPRAZOLAM 278 198 38 B 28 13
RAMIPRIL 258 194 35 31 72
GLIMEPIRIDE 239 151 38 32 32
METHOCARBAMOL 228 149 37 R 33 99
TAMSULOSIN HCL 225 204 33 34 36
RANITIDINE HCL 221 166 42 35 49
ADVAIR DISKUS 218 171 53 36 71
DIOVAN 206 164 23 37 65
BENAZEPRIL HCL 204 164 31 38 68
ZOLPIDEM TARTRATE 197 115 47 39 21
HYDROCHLOROTHIAZIDE 195 175 37 40 15
LISINOPRIL 189 153 39 41 6
LOSARTAN POTASSIUM 187 145 32 42 12
SUCRALFATE 187 153 36 42 140
BACLOFEN 185 92 33 44 132
FLUTICASONE PROPIONATE 173 120 58 45 41
NAMENDA 170 170 14 46 44
SPIRONOLACTONE 169 120 29 47 56
XARELTO 168 168 24 48 167
METFORMIN HCL ER 165 127 26 49 45
CLONAZEPAM 164 73 25 B 50 29
DILTIAZEM ER 161 118 23 51 166
GUANFACINE HCL 154 133 24 R 52 260
PREMARIN 142 118 17 R 53 117
POLYETHYLENE GLYCOL 3350 140 129 45 54 87
LANTUS 134 117 21 55 89
MELOXICAM 132 98 34 56 18
AZITHROMYCIN 129 88 101 57 47
PRADAXA 129 117 19 57 221
PIOGLITAZONE HCL 126 102 16 R 59 105
ENALAPRIL MALEATE 122 117* 18 60 74
MECLIZINE HCL 120 115* 37 61 83
QUETIAPINE FUMARATE 119 76 21 A 62 66
CRESTOR 119 87 22 62 38
ALLOPURINOL 113 91 17 64 34
ONDANSETRON HCL* 106 77 30 65 161
TRIAMCINOLONE ACETONIDE 100 87 59 66 152
METOCLOPRAMIDE HCL 99 80 16 67 115
FENOFIBRATE* 99 58 14 67 60
ZETIA 97 92* 17 69 79
CEPHALEXIN 96 69 64 70 107
PAROXETINE HCL 93 72 12 71 69
CLONIDINE HCL 90 85* 17 72 35
MORPHINE SULFATE ER 89 52 12 S2 73 156
SPIRIVA 89 66 26 73 76
VERAPAMIL ER 88 83* 13 75 88
ESCITALOPRAM OXALATE 86 72 11 76 42
AMITRIPTYLINE HCL 85 52 11 R 77 59
FLUOXETINE HCL 84 41 11 78 64
PROAIR HFA 82 44 25 79 48
SULFAMETHOXAZOLE-TRIMETHOPRIM 80 59 59 80 90
FENTANYL 80 75* 17 S2 80 113
DETROL LA 79 <11 <11 82 208
PROMETHAZINE HCL 78 64 13 R 83 80
TRIAMTERENE-HCTZ 78 <11 <11 83 43
RISPERIDONE 76 <11 <11 A 85 106
PHENYTOIN SODIUM EXTENDED 75 <11 <11 86 147
DOXEPIN HCL 72 <11 <11 87 181
AMIODARONE HCL 72 67* 14 87 151
IBANDRONATE SODIUM 72 51 13 87 291
LEVETIRACETAM 72 <11 <11 87 122
SYNTHROID 70 65* 12 91 78
ROPINIROLE HCL 69 57 14 92 86
DILTIAZEM 24HR CD 66 46 13 93 159
BISOPROLOL FUMARATE 66 53 11 93 141
KLOR-CON 10 65 60* 14 95 104
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 46 11 96 30
LYRICA 62 57* 12 96 51
BUSPIRONE HCL 61 <11 <11 98 109
TORSEMIDE 61 44 14 98 116
NIFEDICAL XL 61 <11 <11 98 216
LOVASTATIN 60 55* 11 101 63
CYPROHEPTADINE HCL 59 44 18 R 102 274
GLIPIZIDE XL 57 <11 <11 103 179
CIPROFLOXACIN HCL 56 43 46 104 55
CARBIDOPA-LEVODOPA 56 51* 14 104 155
HYDRALAZINE HCL 56 <11 <11 104 57
DIAZEPAM 56 56 12 B 104 91
RIVASTIGMINE 55 <11 <11 108 257
AGGRENOX 54 <11 <11 109 232
HYDROCORTISONE 53 48* 11 110 320
ISOSORBIDE MONONITRATE ER 53 48* 11 110 70
LEVOFLOXACIN 53 48* 40 110 61
DILT-XR 52 <11 <11 113 401
NOVOLOG 52 39 16 113 178
GLIPIZIDE 52 <11 <11 113 81
OXYCONTIN 51 <11 <11 S2 116 177
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 28, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.